Background
Methods
Results
Number of cases | (%) | |
---|---|---|
Gender
| ||
Male
| 55 | 51.9 |
Female
| 51 | 48,1 |
Age (years)
| ||
<15
| 15 | 14.2 |
16-34
| 24 | 22.6 |
35-54
| 28 | 26.4 |
>55
| 39 | 36.8 |
Antecedent events
| ||
Upper respiratory infection
| 40 | 37.7 |
Gastrointestinal infection
| 29 | 27.4 |
Vacunation
| 2 | 1.9 |
Others
| 3 | 2.8 |
None
| 32 | 30.2 |
Season
| ||
Winter
| 43 | 40.6 |
Spring
| 20 | 18.9 |
Summer
| 21 | 19.8 |
Autumn
| 22 | 20.8 |
Motor deficit
| ||
Mild (MRC 31–40)
| 60 | 56.6 |
Moderate (MRC 11–30)
| 43 | 40.6 |
Severe (MRC 0–10)
| 3 | 2.8 |
Cranial nerve involvement
| 37 | 35.5 |
Facial palsy uni/bilateral
| 27 | 25.5 |
MOE
| 14 | 13.2 |
Bulbar nerves
| 4 | 3.8 |
Ataxia
| 8 | 7,5 |
Other symptoms
| ||
Sensory deficit
| 31 | 29.2 |
Pain
| 33 | 31.1 |
SNA
| 9 | 8.5 |
SIADH
| 7 | 6.6 |
Respiratory distress
| 18 | 17 |
GBS disability score
| ||
Minor signs or symptoms
| 12 | 11.3 |
Walk without support
| 41 | 38.7 |
Walk with support
| 16 | 15,1 |
Bedridden or chair bound
| 19 | 17.9 |
Ventilated
| 18 | 17 |
Death attributed to SGB
| 2 | 1.9 |
Clinical data
Laboratory and neurophysiological findings
N | CMAP (mV) | MDL (ms) | MCV (m/s) | n | SNAP (μV) | DL(ms) | SCV (m/s) | |
---|---|---|---|---|---|---|---|---|
Median
| 83 | 6,8 ± 5,6 | 6,4 ± 7,8 | 43,6 ± 17,9 | 85 | 7,03 ± 7,8 | 3,2 ± 3,4 | 43,6 ± 16,6 |
Min-Max | 0,07-21,30 | 0,1 ± 61,0 | 0,10 ± 65,5 | 0,1-43,2 | 0,1-27,7 | 0,1-63,4 | ||
Ulnar
| 32 | 8,0 ± 7,8 | 3,4 ± 1,5 | 46,6 ± 17,4 | 72 | 3,9 ± 3,9 | 2,6 ± 1,9 | 43,2 ± 16,4 |
Min-Max | 0,1-16,6 | 0,1-7,5 | 0,1-8,1 | 0,1-19,9 | 0,1-14,2 | 0,1-59,7 | ||
Tibial post
| 14 | 4,8 ± 5,9 | 6,7 ± 2,2 | 33,5 ± 15,6 | ||||
Min-Max | 0,2-18,10 | 4,0-11,0 | 0,1-50,20 | |||||
Peroneal
| 87 | 3,6 ± 3,9 | 6,9 ± 5,1 | 35,9 ± 14,8 | ||||
Min-Max | 0,1-15,7 | 0,1-31,4 | 0,1-54,1 | |||||
Sural
| 71 | 6,01 ± 5,4 | 2,6 ± 1,9 | 39,2 ± 15,5 | ||||
Min-Max | 0,1-27,4 | 0,1-18,0 | 0,1-57,2 | |||||
Sup Peroneal
| 39 | 9,7 ± 8,2 | 2,2 ± 0,7 | 39,8 ± 12,7 | ||||
Min-Max | 0,1-37,4 | 0,1-3,8 | 0,13-8 |
Treatment, outcome and prognosis
Discharge | 3th month revision | 6th month revision | 12th month revision | |||||
---|---|---|---|---|---|---|---|---|
N | (%) | N | (%) | N | (%) | N | (%) | |
Healthy
| 4 | 3,8 | 18 | 29,5 | 17 | 36,2 | 18 | 58,1 |
Minor deficits or symptoms
| 34 | 32,1 | 19 | 31,1 | 15 | 31,9 | 7 | 22,6 |
Walk without support
| 30 | 28,3 | 14 | 23 | 8 | 17 | 2 | 6,5 |
Walk with support
| 28 | 26,4 | 10 | 16,4 | 7 | 14,9 | 4 | 12,9 |
Bedbridden or chairbound
| 7 | 6,6 | 0 | 0 | 0 | |||
Ventilated
| 1 | 0,9 | 0 | 0 | 0 | |||
Death
| 2 | 1,9 | 0 | 0 | 0 |
Discharge deficits | 3th month revision deficits | 6th month revision deficits | 12th month revision deficits | |||||
---|---|---|---|---|---|---|---|---|
Disabling | p | Disabling | p | Disabling | p | Disabling | p | |
Severity at admission
|
<0.001
|
0.001
|
<0.001
|
0.2
| ||||
Non disabling
| 11.3% (6/53) | 20.6% (7/34) | 7.7% (2/26) | 11.8% (2/17) | ||||
Disabling
| 60.3% (32/53) | 63% (17/27) | 61.9% (13/21) | 28.6% (4/14) | ||||
Age
|
0.2
|
0.17
|
0.01
|
0.006
| ||||
<55 years
| 31.3% (21/67) | 34.1% (15/44) | 17.6% (6/34) | 8% (2/25) | ||||
>55 years
| 43.6% (17/39) | 52.9% (9/17) | 69.2% (9/13) | 66.7% (4/69 | ||||
MV
|
0.003
|
0.13
|
0.6
|
1
| ||||
Yes
| 66.7% (12/18) | 66.7% (6/9) | 42.9% (3/7) | 25% (1/4) | ||||
No
| 29.5% (26/88) | 34.6% (18/52) | 30% (12/40) | 18.5% (5/27) | ||||
Axonal lesion at CNS
|
0.2
|
0.3
|
0.06
|
0.4
| ||||
Demyelinating
| 40.7% (22/54) | 43.3% (13/30) | 30.4% (7/23) | 16,7% (3/18) | ||||
Axonal
| 71.4% (5/7) | 66,7% (4/6) | 80% (4/5) | 33.3% (1/3) |